FindTrial
Sign In

Radiation Dose to Pelvic Muscles and Its Effect on Long-Term Pelvic Floor Weakness in Cervical Cancer Survivors

Pelvic Muscle Doses from External Beam Radiotherapy and Brachytherapy and Correlation with Long-Term Pelvic Floor Weakness in Cervix Cancer Survivors - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/108371
Enrollment
200
Registered
2026-04-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

Tata memorial Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: More than 18 years of age Newly diagnosed histologically proven cervical cancer Patients undergoing Radical Radiotherapy with or without chemotherapy. Disease-free and on routine clinical follow up as per standard of care.

Exclusion criteria

Exclusion criteria: Did not complete brachytherapy treatment Cervical cancer patients receiving Primary Surgery followed by adjuvant radiotherapy Patients with metastatic disease or those treated with palliative intent. Patients with recurrent disease, second primary, synchronous primary

Design outcomes

Primary

MeasureTime frame
Incidence and prevalence of incontinence symptoms with EBRT and bravhytherapy in case of carcinoma cervixTimepoint: 03 years—

Secondary

MeasureTime frame
Correlate the pelvic muscle dose EDQ2 and faecal and urinary incontinence symptoms after external beam radiotherapy and image guided brachytherapyTimepoint: 03 years—

Countries

India

Contacts

Public ContactDr Supriya Chopra

Tata Memorial Centre

drshantanuradonco@gmail.com9509655927

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026